Association between ACE gene I/D polymorphism and clinical presentation and prognosis of sarcoidosis

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 65, Issue 8, 2005, Pages 691-698

  Alia P ^a   Mana J ^a   Capdevila, O ^a   Alvarez A ^a   Navarro, M A ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

Author keywords

ACE concentration; ACE gene polymorphism; Angiotensin converting enzyme (ACE); L fgren's syndrome; Sarcoidosis; Sarcoidosis activity

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ACUTE DISEASE; ADULT; ALLELE; ARTICLE; CHRONIC DISEASE; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; ENZYME ACTIVITY; ENZYME KINETICS; FEMALE; FOLLOW UP; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 28744453056     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.1080/00365510500354128     Document Type: Article

References (26)

1. Hunninghake G, Costabel U, Ando M, Baughman R, Cordier JF, DuBois R, et al. Statement on sarcoidosis. Am J Respir Crit Care Med 1999;160:736-55.
2. McGrath D, Goh N, Foley PJ, du Bois RM. Sarcoidosis: genes and microbes - soil or seed? Sarcoidosis Vasc Diffuse Lung Dis 2001;18:149-64.
3. Luisetti M, Beretta A, Casali L. Genetic aspects in sarcoidosis. Eur Respir J 2000;16:768-80.
4. Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001;164:840-6.
5. Du Bois R. Sarcoidosis: Do our genes really matter? Am J Respir Crit Care Med 2001;164:725-6.
6. Costabel U, Teschler H. Biochemical changes in sarcoidosis. Clin Chest Med 1997;18:827-42.
7. Mañá J, Salazar A, Pujol R, Manresa F. Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis? Respiration 1996;63:298-303.
8. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
9. Furuya K, Yamaguchi E, Itoh A, Hizawa N, Ohnuma N, Kojima J, et al. Deletion polymorphism in the angiotensin I converting enzyme (ACE) gene as a genetic risk factor for sarcoidosis. Thorax 1996;51:777-80.
10. Maliarik M, Rybicki BA, Malvitz E, Sheffer RG, Major M, Popovich J Jr, et al. Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med 1998;158:1566-70.
11. McGrath D, Foley PJ, Petrek M, Izakovicova-Holla L, Kolek V, Veeraraghavan S, et al. ACE gene I/D polymorphism and sarcoidosis pulmonary disease severity. Am J Respir Crit Care Med 2001;164:197-201.
12. Schurmann M, Reichel P, Muller-Myhsok B, Dieringer T, Wurm K, Schlaak M, et al. Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis. J Intern Med 2001;249:77-83.
13. Mañá J, Gómez-Vaquero C, Montero A, Salazar A, Marcoval J, Valverde J, et al. Löfgren's syndrome revisited: a study of 186 patients. Am J Med 1999;107:240-5.
14. Neville E, Walker AN, James DG. Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients. Q J Med 1983;52:525-33.
15. Mañá J, Salazar A, Manresa F. Clinical factors predicting persistence of activity in sarcoidosis: a multivariate analysis of 193 cases. Respiration 1994;61:219-25.
16. Holmquist B, Bunning P, Riordan JF. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem 1979;95:540-8.
17. Tomita H, Ina Y, Sugiura Y, Sato S, Kawaguchi H, Morishita M, et al. Polymorphism in the angiotensin-converting enzyme (ACE) gene in sarcoidosis. Am J Respir Crit Care Med 1997;156:255-9.
18. Arbustini E, Grasso M, Leo G, Tinelli C, Fasani R, Diegoli M, et al. Polymorphism of angiotensin-converting enzyme gene in sarcoidosis. Am J Respir Crit Care Med 1996;153:851-4.
19. Pietinalho A, Furuya K, Yamaguchi E, Kawakami Y, Selroos O. The angiotensin-converting enzyme DD gene is associated with poor prognosis in Finnish sarcoidosis patients. Eur Respir J 1999;13:723-6.
20. Papadopoulos K, Melander O, Orho-Melander M, Groop LC, Carlsson M, Hallengren B. Angiotensin converting enzyme (ACE) gene polymorphism in sarcoidosis in relation to associated autoimmune diseases. J Intern Med 2000;247:71-7.
21. Sharma P, Smith I, Maguire G, Stewart S, Shneerson J, Brown MJ. Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 1997;349:1602-3.
22. Csaszar A, Halmos B, Palicz T, Szalai C, Romics L. Interpopulation effect of ACE I/D polymorphism on serum concentration of ACE in diagnosis of sarcoidosis. Lancet 1997;350:518.
23. Muller B. Analysis of serum angiotensin-converting enzyme. Ann Clin Biochem 2002;39:436-43.
24. Ruprecht B, Schurmann M, Ziegenhagen MW, vom Bauer E, Meier D, Schlaak M, et al. [Corrected normal values for serum ACE by genotyping the deletion-/insertion-polymorphism of the ACE gene] [Article in German]. Pneumologie 2001;55:326-32.
25. Romer F. The level of angiotensin-converting enzyme as indicator of 2 year prognosis in untreated pulmonary sarcoidosis without erythema nodosum. Acta Med Scand 1982;211:293-5.
26. Ueda E, Kawabe T, Tachibana T, Kokubu T. Serum angiotensin converting enzyme activity as an indicator of prognosis in sarcoidosis. Am Rev Respir Dis 1980;121:667-71.